SA
Sign upLog In

Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

EBITDA

$514.70M

TTM · Period ending: · USD

BIO logo

BIO EBITDA

Latest reported$514.70M
BIO TTM EBITDA ($11.80M → $514.70M)
High-resolution chart · PNG

BIO ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
139,295,000
131,938,000
120,764,000
118,180,000
105,040,000
93,847,000
76,032,000
67,332,000
62,032,000
55,838,000
52,100,000
49,100,000
49,600,000
49,600,000
46,300,000
49,500,000
54,700,000
56,700,000
59,900,000
59,300,000
58,200,000
57,500,000
56,300,000
55,700,000
55,000,000
54,800,000
53,500,000
45,100,000
39,900,000
34,000,000
26,900,000
30,200,000
31,000,000
23,900,000
28,500,000
27,600,000
28,800,000
36,400,000
34,200,000
37,600,000
36,200,000
36,200,000
34,700,000
30,500,000
29,500,000
29,700,000
76,600,000
-55,900,000
-15,500,000
25,700,000
19,900,000
46,700,000
39,500,000
29,400,000
16,400,000
34,700,000
26,800,000
19,300,000
11,800,000
26,100,000
20,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.